LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Eurofins’ organic growth momentum remains robust: Objectives Comments from the CEO, Dr Gilles Martin: “Despite the ...
Hill projected core organic growth “to improve to approximately 3% in the second half of 2025.” He expects Q3 2025 reported total revenue between $46.8 million and $52.8 million, and adjusted EBITDA ...
For Q4 2025, Michael Hill provided guidance: "we expect reported total revenue to be between $46.4 million and $52.4 million, including subscription and support revenue between $44.1 million and $49.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results